Lipocine Depreciation & Amortization 2011-2026 | LPCN

Annual Depreciation & Amortization Lipocine

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
60.8 K	41.1 K	28.7 K	9.45 K	380	3.55 K	15.4 K	18.6 K	28.4 K	32 K	26.7 K	14.6 K	21.8 K	42.6 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
60.8 K	380	24.6 K

Quarterly Depreciation & Amortization Lipocine

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
14.8 K	-	-	15.6 K	-	-	-	8.51 K	-	-	-	4.82 K	-	6.88 K	4.3 K	1.72 K	-	-	-	-	-	2.4 K	1.6 K	799	-	11.6 K	7.72 K	3.86 K	-	14.2 K	9.71 K	5.26 K	-	21.3 K	14.2 K	7.09 K	-	23.7 K	15.5 K	6.65 K	-	19.6 K	8.72 K	4.3 K	-	9.39 K	6.06 K	3.03 K	-	15.7 K	10.5 K	5.24 K	-	31.6 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
31.6 K	799	9.88 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	1.3 M	$ 1.59	-3.64 %	$ 186 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Celldex Therapeutics CLDX	3.38 M	$ 31.43	-0.85 %	$ 2.09 B	USA
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 56.18	-0.35 %	$ 5.05 B	Schweiz
Compugen Ltd. CGEN	475 K	$ 2.63	-5.4 %	$ 246 M	Israel
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Enlivex Therapeutics Ltd. ENLV	332 K	$ 0.81	6.0 %	$ 37 M	Israel
Esperion Therapeutics ESPR	105 K	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 30.45	-4.43 %	$ 819 M	USA
Forte Biosciences FBRX	64 K	$ 19.07	-8.18 %	$ 247 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Galectin Therapeutics GALT	1 K	$ 2.52	-1.95 %	$ 161 M	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Heron Therapeutics HRTX	2.31 M	$ 0.87	-2.44 %	$ 145 M	USA
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
ImmuCell Corporation ICCC	2.78 M	$ 10.24	3.43 %	$ 92.4 M	USA
Anika Therapeutics ANIK	5.37 M	$ 14.53	-2.48 %	$ 208 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.35	-0.3 %	$ 5.51 M	Israel
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada